Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis
Monica Margoni, Francesca Rinaldi, Silvia Miante, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2019) Vol. 5, Iss. 3
Open Access | Times Cited: 15

Showing 15 citing articles:

Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment
Dejan Jakimovski, Samreen Awan, Svetlana Eckert, et al.
CNS Drugs (2021) Vol. 36, Iss. 1, pp. 45-59
Open Access | Times Cited: 50
Old and New Strategies in the Treatment of Pediatric Multiple Sclerosis: A Personal View for a New Treatment Approach
Angelo Ghezzi
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 949-963
Open Access | Times Cited: 5
Therapeutic Advances in Pediatric Multiple Sclerosis
R. J. Walsh, Tanuja Chitnis
Children (2025) Vol. 12, Iss. 3, pp. 259-259
Open Access
Pediatric Multiple Sclerosis: A Systematic Exploration of Effectiveness in Current and Emerging Therapeutics
Padideh Panahi, Seyedeh-Tarlan Mirzohreh, Hooman Zafardoust, et al.
Pediatric Neurology (2025)
Closed Access
Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
Monica Margoni, Francesca Rinaldi, Paola Perini, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 26
Current and Emerging Treatment Options in Pediatric Onset Multiple Sclerosis
Artemis Mavridi, Maria Eleni Bompou, Aine Redmond, et al.
Sclerosis (2024) Vol. 2, Iss. 2, pp. 88-107
Open Access | Times Cited: 3
Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis
Marco Puthenparampil, Marta Gaggiola, Alessandro Miscioscia, et al.
Therapeutic Advances in Neurological Disorders (2023) Vol. 16
Open Access | Times Cited: 8
Short-term outcomes of pediatric multiple sclerosis patients treated with alemtuzumab at a Canadian University multiple sclerosis clinic
David Jure Hunt, Anthony Traboulsee
Multiple Sclerosis Journal - Experimental Translational and Clinical (2020) Vol. 6, Iss. 2
Open Access | Times Cited: 15
Current and Emerging Treatment Options in Pediatric Onset Multiple Sclerosis
Artemis Mavridi, Maria Eleni Bompou, Aine Margaret Redmond, et al.
(2024)
Open Access | Times Cited: 1
Product review on MAbs (alemtuzumab and ocrelizumab) for the treatment of multiple sclerosis
Tereza Gabelić, Barbara Barun, Ivan Adamec, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 11, pp. 4345-4362
Open Access | Times Cited: 10
Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials?
Gıancarlo Comı, Gloria Dalla Costa, Lucia Moiola
Expert Review of Neurotherapeutics (2020) Vol. 21, Iss. 1, pp. 21-34
Closed Access | Times Cited: 9
Treatment of multiple sclerosis in children: review of clinical trials
Luizat М. Abdullaeva, Б. И. Бурсагова, А. Л. Куренков, et al.
L O Badalyan Neurological Journal (2023) Vol. 4, Iss. 1, pp. 43-51
Open Access | Times Cited: 2
Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic
Monica Margoni, Paolo Gallo
Multiple Sclerosis Journal - Experimental Translational and Clinical (2020) Vol. 6, Iss. 4, pp. 205521732096634-205521732096634
Open Access | Times Cited: 4
Pediatric multiple sclerosis and acute disseminated encephalomyelitis
Kimberly A. O'Neill, Cristina Fernandez-Carbonell, Mirjana Maletić‐Savatić, et al.
Elsevier eBooks (2024), pp. 1525-1547
Closed Access
Optimizing Drug Selection in Children with Multiple Sclerosis: What Do We Know and What Remains Unanswered?
Rabporn Suntornlohanakul, E. Ann Yeh
Pediatric Drugs (2024)
Closed Access
Page 1

Scroll to top